Natural antioxidants: Therapeutic prospects for cancer and neurological diseases

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 10, 2009, Pages 1202-1214

  Mates J M ^a   Segura, J A ^a   Alonso, F J ^a   Marquez J ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Celastrol; Curcumin; Flavonoid; Polyphenol; Proteasome; Resveratrol; Silymarin

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; CELASTROL; CHROMIUM; CURCUMIN; GELATINASE A; GELDANAMYCIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEME OXYGENASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NITRIC OXIDE; PICEATANNOL; POLYPHENOL DERIVATIVE; PROTEASOME; PROTEASOME INHIBITOR; RESVERATROL; SILENT INFORMATION REGULATOR PROTEIN; SILENT INFORMATION REGULATOR PROTEIN 2; SILYMARIN; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER PREVENTION; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL STRESS; COLON TUMOR; DIET; DNA DAMAGE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MECHANISM; DRUG MEGADOSE; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESOPHAGUS TUMOR; HUMAN; INTESTINE TUMOR; LEUKEMIA; LIVER PROTECTION; LUNG METASTASIS; LYMPHOMA; MELANOMA; METASTASIS; METASTASIS INHIBITION; NEOPLASM; NEUROBLASTOMA; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN CONFORMATION; PROTEIN DEGRADATION; RADIATION PROTECTION; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN CANCER; TRANSCRIPTION REGULATION; ULTRAVIOLET B RADIATION;

ANIMALS; ANTIOXIDANTS; HUMANS; NEOPLASMS; NERVOUS SYSTEM DISEASES;

EID: 70450217032     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709789055180     Document Type: Short Survey

References (99)

1. Lora, J.; Alonso, F. J.; Segura, J. A.; Lobo, C.; Márquez, J.; Matés, J.M. Antisense glutaminase inhibition decreases glutathione antioxidant capacity and increases apoptosis in Ehrlich ascitic tumour cells. Eur. J. Biochem., 2004, 271, 4298-4306
2. Matés, J. M.; Pérez-Gómez, C.; Núñez de Castro, I. Antioxidant enzymes and human diseases. Clin. Biochem., 1999, 32, 595-603.
3. Matés, J. M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology, 2000, 153, 83-104.
4. Gosslau, A.; Rensing, L. Z. Oxidative stress, age-dependent [correction of age-related] cell damage and antioxidative mechanisms. Gerontol. Geriatr., 2002, 35, 139-150
5. Matés, J. M.; Pérez-Gómez, C.; Núñez de Castro, I.; Asenjo, M.; Márquez, J. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int. J. Biochem. Cell Biol., 2002, 34, 439-458
6. Matés, J. M.; Segura, J. A.; Alonso, F. J.; Márquez, J. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch. Toxicol., 2008, 82, 273-299
7. Matés, J. M.; Segura, J. A.; Alonso, F. J.; Márquez, J. Pathways from glutamine to apoptosis. Front. Biosci., 2006, 11, 3164-3180
8. Kawanishi, S.; Oikawa, S.; Murata, M. Evaluation for safety of antioxidant chemopreventive agents. Antioxid. Redox Signal., 2005, 7, 1728-1739
9. Gerhäuser, C.; Klimo, K.; Heiss, E.; Neumann, I.; Gamal-Eldeen, A.; Knauft, J.; Liu, G. Y.; Sitthimonchai, S.; Frank, N. Mechanismbased in vitro screening of potential cancer chemopreventive agents. Mutat. Res., 2003, 523-524, 163-172
10. Lee, N. H.; Ho, J. W. Celastrol and terpenes as anti-infective agents. Anti-Infect. Agents Med. Chem., 2008, 7, 97-100.
11. Chang, F. R.; Hayashi, K.; Chen, I. H.; Liaw, C. C.; Bastow, K. F.; Nakanishi, Y.; Nozaki, H.; Cragg, G. M.; Wu, Y. C.; Lee, K. H. J. Antitumor agents. 228. five new agarofurans, Reissantins A-E, and cytotoxic principles from Reissantia buchananii. Nat. Prod., 2003, 66, 1416-1420
12. Ngassapa, O.; Soejarto, D. D.; Pezzuto, J. M.; Farnsworth, N. R. Quinone-methide triterpenes and salaspermic acid from Kokoona ochracea. J. Nat. Prod., 1994, 57, 1-8.
13. Yang, H.; Chen, D.; Cui, Q. C.; Yuan, X.; Dou, Q. P. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res., 2006, 66, 4758-4765
14. Zhang, T.; Hamza, A.; Cao, X.; Wang, B.; Yu, S.; Zhan, C. G.; Sun, D. A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells. Mol. Cancer Ther., 2008, 7, 162-170
15. Abbas, S.; Bhoumik, A.; Dahl, R.; Vasile, S.; Krajewski, S.; Cosford, N. D.; Ronai, Z. A. Preclinical studies of celastrol and acetyl isogambogic acid in melanoma. Clin. Cancer Res., 2007, 13, 6769-6778
16. Westerheide, S. D.; Bosman, J. D.; Mbadugha, B. N.; Kawahara, T. L.; Matsumoto, G.; Kim, S.; Gu, W.; Devlin, J. P.; Silverman, R. B.; Morimoto, R. I. Celastrols as inducers of the heat shock response and cytoprotection. J. Biol. Chem., 2004, 279, 56053-56060
17. Trott, A.; West, J. D.; Klaic, L.; Westerheide, S. D.; Silverman, R. B.; Morimoto, R. I.; Morano, K. A. Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule. Mol. Biol. Cell., 2008, 19, 1104-1112
18. Hieronymus, H.; Lamb, J.; Ross, K. N.; Peng, X. P.; Clement, C.; Rodina, A.; Nieto, M.; Du, J.; Stegmaier, K.; Raj, S. M.; Maloney, K. N.; Clardy, J.; Hahn, W. C.; Chiosis, G.; Golub, T. R. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell, 2006, 10, 321-330
19. Yang, H.; Murthy, S.; Sarkar, F. H.; Sheng, S.; Reddy, G. P.; Dou, Q. P. Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells. J. Cell. Physiol., 2008, 217, 569-576
20. Sethi, G.; Ahn, K. S.; Pandey, M. K.; Aggarwal, B. B. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood, 2007, 109, 2727-2735
21. Lee, J. H.; Koo, T. H.; Yoon, H.; Jung, H. S.; Jin, H. Z.; Lee, K.; Hong, Y. S.; Lee, J. J. Inhibition of NF-kappaB activation through targeting I kappaB kinase by celastrol, a quinone methide triterpenoid. Biochem. Pharmacol., 2006, 72, 1311-1321
22. Cao, J.; Jia, L.; Zhou, H. M.; Liu, Y.; Zhong, L. F. Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol. Sci., 2006, 91, 476-483
23. Bonfili, L.; Cecarini, V.; Amici, M.; Cuccioloni, M.; Angeletti, M.; Keller, J. N.; Eleuteri, A. M. Natural polyphenols as proteasome modulators and their role as anti-cancer compounds. FEBS J., 2008, 275, 5512-5526
24. Chen, H. W.; Huang, H. C. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br. J. Pharmacol., 1998, 124, 1029-1040
25. Su, C. C.; Yang, J. S.; Lin, S. Y.; Lu, H. F.; Lin, S. S.; Chang, Y. H.; Huang, W. W.; Li, Y. C.; Chang, S. J.; Chung, J. G. Curcumin inhibits WEHI-3 leukemia cells in BALB/c mice in vivo. In Vivo, 2008, 22, 63-68
26. Garg, R.; Gupta, S.; Maru, G. B. Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action. Carcinogenesis, 2008, 29, 1022-1032
27. Polasa, K.; Naidu, A. N.; Ravindranath, I.; Krishnaswamy, K. Inhibition of B(a)P induced strand breaks in presence of curcumin. Mutat. Res., 2004, 557, 203-213
28. Afaq, F.; Adhami, V. M.; Ahmad, N.; Mukhtar, H. Botanical antioxidants for chemoprevention of photocarcinogenesis. Front. Biosci., 2002, 7, d784-92.
29. Huang, M. T.; Lou, Y. R.; Xie. J. G.; Ma, W.; Lu, Y. P.; Yen, P.; Zhu, B. T.; Newmark, H.; Ho, C. T. Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis, 1998, 19, 1697-1700
30. Menon, V. P.; Sudheer, A. R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol., 2007, 595, 105-125
31. Eybl, V.; Kotyzová, D.; Lesetický, L.; Bludovská, M.; Koutenský, J. The influence of curcumin and manganese complex of curcumin on cadmium-induced oxidative damage and trace elements status in tissues of mice. J. Appl. Toxicol., 2006, 26, 207-212
32. Jagetia, G. C. Radioprotection and radiosensitization by curcumin. Adv. Exp. Med. Biol., 2007, 595, 301-320
33. Woo, J. H.; Kim, Y. H.; Choi, Y. J.; Kim, D. G.; Lee, K. S.; Bae, J. H.; Min, D. S.; Chang, J. S.; Jeong, Y. J.; Lee, Y. H.; Park, J. W.; Kwon, T. K. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis, 2003, 24, 1199-1208.
34. Frank, N.; Knauft, J.; Amelung, F.; Nair, J.; Wesch, H.; Bartsch, H. No prevention of liver and kidney tumors in Long-Evans Cinnamon rats by dietary curcumin, but inhibition at other sites and of metastases. Mutat. Res., 2003, 523-524, 127-135
35. Sreepriya, M.; Bali, G. Effects of administration of embelin and curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Mol. Cell. Biochem., 2006, 284, 49-55.
36. Sakano, K.; Kawanishi, S. Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes. Arch. Biochem. Biophys., 2002, 405, 223-230
37. Vitrac, X.; Bornet, A.; Vanderlinde, R.; Valls, J.; Richard, T.; Delaunay, J. C.; Mérillon, J. M.; Teissédre, P. L. Determination of stilbenes (delta-viniferin, trans-astringin, trans-piceid, cis- and trans-resveratrol, epsilon-viniferin) in Brazilian wines. J. Agric. Food. Chem., 2005, 53, 5664-5669
38. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov., 2006, 5, 493-506.
39. Athar, M.; Back, J. H.; Tang, X.; Kim, K.H.; Kopelovich, L.; Bickers, D.R.; Kim, A.L. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol., 2007, 224, 274-283
40. Kode, A.; Rajendrasozhan, S.; Caito, S.; Yang, S. R.; Megson, I. L.; Rahman, I. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 2008, 294, L478-88.
41. Quincozes-Santos, A.; Andreazza, A. C.; Nardin, P.; Funchal, C.; Gonçalves, C. A.; Gottfried, C. Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells. Neurotoxicology, 2007, 28, 886-891
42. Kaindl, U.; Eyberg, I.; Rohr-Udilova, N.; Heinzle, C.; Marian, B. The dietary antioxidants resveratrol and quercetin protect cells from exogenous pro-oxidative damage. Food Chem. Toxicol., 2008, 46, 1320-1326
43. Nam, N. H. Naturally occurring NF-kappaB inhibitors. Mini Rev. Med. Chem., 2006, 6, 945-951
44. Rimando, A. M.; Cuendet, M.; Desmarchelier, C.; Mehta, R. G.; Pezzuto, J. M.; Duke, S. O. Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J. Agric. Food Chem., 2002, 50, 3453-3457
45. Schwarz, D.; Roots, I. In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1. Biochem. Biophys. Res. Commun., 2003, 303, 902-907
46. 2 is protected by the antioxidants melatonin, N(1)-acetyl-N(2)- formyl-5-methoxykynuramine, resveratrol and uric acid. Int. J. Biochem. Cell Biol., 2001, 33, 775-783
47. Ebert, B.; Seidel, A.; Lampen, A. Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate. Toxicol. Sci., 2007, 96, 227-236
48. Ho, S. M. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J. Cell. Biochem., 2004, 91, 491-503.
49. Breinholt, V. M.; Mølck, A. M.; Svendsen, G. W.; Daneshvar, B.; Vinggaard, A. M.; Poulsen, M.; Dragsted, L. O. Effects of dietary antioxidants and 2-amino-3-methylimidazo[4,5-f]- quinoline (IQ) on preneoplastic lesions and on oxidative damage, hormonal status, and detoxification capacity in the rat. Food Chem. Toxicol., 2003, 41, 1315-1323
50. Ramasamy, K.; Agarwal, R. Multitargeted therapy of cancer by silymarin. Cancer Lett., 2008, 269, 352-362
51. Wu, J. W.; Lin, L. C.; Hung, S. C.; Lin, C. H.; Chi, C. W.; Tsai, T. H. Hepatobiliary excretion of silibinin in normal and liver cirrhotic rats. Drug Metab. Dispos., 2008, 36, 589-596
52. Sun, N.; Zhang, X.; Lu, Y.; Wu, W. In vitro evaluation and pharmacokinetics in dogs of solid dispersion pellets containing Silybum marianum extract prepared by fluid-bed coating. Planta Med., 2008, 74, 126-132
53. Saller, R.; Melzer, J.; Reichling, J.; Brignoli, R.; Meier, R. An updated systematic review of the pharmacology of silymarin. Forsch. Komplementmed., 2007, 14, 70-80.
54. Katiyar, S. K. Treatment of silymarin, a plant flavonoid, prevents ultraviolet light-induced immune suppression and oxidative stress in mouse skin. Int. J. Oncol., 2002, 21, 1213-1222
55. Gu, M.; Singh, R. P.; Dhanalakshmi, S.; Agarwal, C.; Agarwal, R. Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res., 2007, 67, 3483-3491
56. Singh, R. P.; Gu, M.; Agarwal, R. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res., 2008, 68, 2043-2050
57. Yanaida, Y.; Kohno, H.; Yoshida, K.; Hirose, Y.; Yamada, Y.; Mori, H.; Tanaka, T. Dietary silymarin suppresses 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Carcinogenesis, 2002, 23, 787-794
58. Singh, R. P.; Deep, G.; Chittezhath, M.; Kaur, M.; Dwyer-Nield, L. D.; Malkinson, A. M.; Agarwal, R. Effect of silibinin on the growth and progression of primary lung tumors in mice. J. Natl. Cancer Inst., 2006, 98, 846-855 (Pubitemid 43923441)
59. Chow, A. M.; Brown, I. R. Induction of heat shock proteins in differentiated human and rodent neurons by celastrol. Cell Stress Chaperones, 2007, 12, 237-244
60. Zhang, Y. Q.; Sarge, K. D. Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response. J. Mol. Med., 2007, 85, 1421-1428
61. Brown, I. R. Heat shock proteins and protection of the nervous system. Ann. N. Y. Acad. Sci., 2007, 1113, 147-158 (Pubitemid 350015026)
62. Kiaei, M.; Kipiani, K.; Petri, S.; Chen, J.; Calingasan, N. Y.; Beal, M. F. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis., 2005, 2, 246-254 (Pubitemid 43805908)
63. Cleren, C.; Calingasan, N. Y.; Chen, J.; Beal, M. F. Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. J. Neurochem., 2005, 94, 995-1004. (Pubitemid 41170587)
64. Allison, A. C.; Cacabelos, R.; Lombardi, V. R.; Alvarez, X. A.; Vigo, C. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2001, 25, 1341-1357
65. Wang, Q.; Sun, A. Y.; Simonyi, A.; Jensen, M. D.; Shelat, P. B.; Rottinghaus, G. E.; MacDonald, R. S.; Miller, D. K.; Lubahn, D. E.; Weisman, G. A.; Sun, G. Y. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J. Neurosci. Res., 2005, 82, 138-148
66. Al-Omar, F. A.; Nagi, M. N.; Abdulgadir, M. M.; Al Joni, K. S.; Al-Majed, A. A. Immediate and delayed treatments with curcumin prevents forebrain ischemia-induced neuronal damage and oxidative insult in the rat hippocampus. Neurochem. Res., 2006, 31, 611-618 (Pubitemid 43886409)
67. Vajragupta, O.; Boonchoong, P.; Watanabe, H.; Tohda, M.; Kummasud, N.; Sumanont, Y. Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity. Free Radic. Biol. Med., 2003, 35, 1632-1644 (Pubitemid 37532914)
68. Sumanont, Y.; Murakami, Y.; Tohda, M.; Vajragupta, O.; Watanabe, H.; Matsumoto, K. Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin. Life Sci., 2006, 78, 1884-1891 (Pubitemid 43295589)
69. Scapagnini, G.; Butterfield, D. A.; Colombrita, C.; Sultana, R.; Pascale, A.; Calabrese, V. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid. Redox Signal., 2004, 6, 811-818 (Pubitemid 39237933)
70. Scapagnini, G.; Colombrita, C.; Amadio, M.; D'Agata, V.; Arcelli, E.; Sapienza, M.; Quattrone, A.; Calabrese, V. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid. Redox Signal., 2006, 8, 395-403. (Pubitemid 43741311)
71. Zhu, Y. G.; Chen, X. C.; Chen, Z. Z.; Zeng, Y. Q.; Shi, G. B.; Su, Y. H.; Peng, X. Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons. Acta Pharmacol. Sin., 2004, 25, 1606-1612 (Pubitemid 39628027)
72. Yang, F.; Lim, G. P.; Begum, A. N.; Ubeda, O. J.; Simmons, M. R.; Ambegaokar, S. S.; Chen, P. P.; Kayed, R.; Glabe, C. G.; Frautschy, S. A.; Cole, G. M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem., 2005, 280, 5892-5901
73. Frautschy, S. A.; Hu, W.; Kim, P.; Miller, S. A.; Chu, T.; Harris-White, M. E; Cole, G. M. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging, 2001, 22, 993-1005.
74. Cole, G. M.; Lim, G. P.; Yang, F.; Teter, B.; Begum, A.; Ma, Q.; Harris-White, M. E.; Frautschy, S. A. Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol. Aging, 2005, 26, 133-136
75. Huang, S. S.; Tsai, M. C.; Chih, C. L.; Hung, L. M.; Tsai, S. K. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci., 2001, 69, 1057-1065. (Pubitemid 32701916)
76. Sinha, K.; Chaudhary, G.; Gupta, Y, K. Protective effect of resveratrol agaist oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci., 2002, 71, 655-665. (Pubitemid 34628827)
77. Wang, Q.; Xu, J.; Rottinghaus, G. E.; Simonyi, A.; Lubahn, D.; Sun, G. Y.; Sun, A. Y. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res., 2002, 958, 439-447
78. Inoue, H.; Jiang, X. F.; Katayama, T.; Osada, S.; Umesono, K.; Mamura, S. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice. Neurosci. Lett., 2003, 352, 203-206
79. Bastianetto, S.; Quirion, R. Natural extracts as possible protective agents of brain aging. Neurobiol. Aging, 2002, 23, 891-897 (Pubitemid 35217714)
80. Ban, J. Y.; Cho, S. O.; Choi, S. H.; Ju, H. S.; Kim, J. Y.; Bae, K.; Song, K. S.; Seong, Y. H. Neuroprotective effect of Smilacis chinae rhizome on NMDA-induced neurotoxicity in vitro and focal cerebral ischemia in vivo. J. Pharmacol. Sci., 2008, 106, 68-77.
81. Marambaud, P.; Zhao, H.; Davies, P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem., 2005, 280, 37377-37382 (Pubitemid 41642343)
82. Kim, H. J.; Lee, K. W.; Lee, H. J. Protective effects of piceatannol against beta-amyloid-induced neuronal cell death. Ann. N. Y. Acad. Sci., 2007, 1095, 473-482 (Pubitemid 47092478)
83. Conte, A.; Pellegrini, S.; Tagliazucchi, D. Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin. Res. Bull., 2003, 62, 29-38. (Pubitemid 37330112)
84. Pallàs, M.; Verdaguer, E.; Tajes, M.; Gutierrez-Cuesta, J.; Camins, A. Modulation of sirtuins: new targets for antiageing. Recent Pat. CNS Drug Discov., 2008, 3, 61-69 (Pubitemid 351223186)
85. Dasgupta, B.; Milbrandt, J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. USA, 2007, 104, 7217-7222 (Pubitemid 47186035)
86. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; Geny, B.; Laakso, M.; Puigserver, P.; Auwerx, J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006, 127, 1109-1122
87. Sun, A. Y.; Sun, G. Y. Ethanol and oxidative mechanisms in the brain. J. Biomed. Sci., 2001, 8, 37-43.
88. Antonio, A. M.; Druse, M. J. Antioxidants prevent ethanol-associated apoptosis in fetal rhombencephalic neurons. Brain Res., 2008, 1204, 16-23.
89. Wang, M. J.; Lin, W. W.; Chen, H. L.; Chang, Y. H.; Ou, H. C.; Kuo, J. S.; Hong, J. S.; Jeng, K. C. Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur. J. Neurosci., 2002, 16, 2103-2112
90. Soliman, K. F.; Mazzio, E. A. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc. Soc. Exp. Biol. Med., 1998, 218, 390-397 (Pubitemid 28381801)
91. Allain, H.; Schück, S.; Lebreton, S.; Strenge-Hesse, A.; Braun, W.; Gandon, J. M.; Brissot, P. Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 1999, 10, 181-185 (Pubitemid 29224493)
92. Sakai, K.; Li, Y.; Shirakawa, T.; Kitagawa, Y.; Hirose, G. Induction of major histocompatibility complex class I molecules on human neuroblastoma line cells by a flavoid antioxidant. Neurosci. Lett., 2001, 298, 127-130 (Pubitemid 32037072)
93. Furst, A. Can nutrition affect chemical toxicity? Int. J. Toxicol., 2002, 21, 419-424 (Pubitemid 35332441)
94. Yang, H.; Landis-Piwowar, K. R.; Chen, D.; Milacic, V.; Dou, Q. P. Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr. Protein. Pept. Sci., 2008, 9, 227-239 (Pubitemid 351997839)
95. Srichairatanakool, S.; Thephinlap, C.; Phisalaphong, C.; Porter, J. B.; Fucharoen, S. Curcumin contributes to in vitro removal of nontransferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. Med. Chem., 2007, 3, 469-474 (Pubitemid 47455737)
96. Fritzer-Szekeres, M.; Savinc, I.; Horvath, Z.; Saiko, P.; Pemberger, M.; Graser, G.; Bernhaus, A.; Ozsvar-Kozma, M.; Grusch, M.; Jaeger, W.; Szekeres, T. Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells-synergism with Ara-C. Int. J. Oncol., 2008, 33, 887-892
97. Kuo, P. L.; Hsu, Y. L. The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing Fas/membrane bound Fas ligand-mediated apoptotic pathway. Mol. Nutr. Food Res., 2008, 52, 408-418
98. Koenig, M. L.; Meyerhoff, J. L. In vitro neuroprotection against oxidative stress by pre-treatment with a combination of dihydrolipoic acid and phenyl-butyl nitrones. Neurotox. Res., 2003, 5, 265-272
99. Begum, A. N.; Jones, M. R.; Lim, G. P.; Morihara, T.; Kim, P.; Heath, D. D.; Rock, C. L.; Pruitt, M. A.; Yang, F.; Hudspeth, B.; Hu, S.; Faull, K. F.; Teter, B.; Cole, G. M.; Frautschy, S. A. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J. Pharmacol. Exp. Ther., 2008, 326, 196-208.